title: Compassionate-use oxaliplatin with bolus 5-fluorouracil/leucovorin in heavily pretreated patients with advanced colorectal cancer.
authors.affiliation: Kentuckiana Cancer Institute, PLLC, Louisville, KY, USA.
authors.forename: Renato V
authors.initials: RV
authors.lastname: LaRocca
authors.forename: Shawn D
authors.initials: SD
authors.lastname: Glisson
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Hargis
authors.forename: Rodney E
authors.initials: RE
authors.lastname: Kosfeld
authors.forename: Karen E
authors.initials: KE
authors.lastname: Leaton
authors.forename: Rebecca M
authors.initials: RM
authors.lastname: Hicks
authors.forename: Falguni
authors.initials: F
authors.lastname: Amin-Zimmerman
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D009362:Neoplasm Metastasis; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D002955:Leucovorin; D005472:Fluorouracil